Multiple café-au-lait spots

From WikiMD's WELLNESSPEDIA

Alternate names[edit]

NF6; Multiple cafe´-au-lait syndrome; Familial cafe´-au-lait spots; Multiple cafe´-au-lait spots; Multiple cafe-au-lait spots; Autossomal dominant café-au-lait spots; Neurofibromatosis type 6

Definition[edit]

Neurofibromatosis type 6 (NF6), also referred as café-au-lait spots syndrome, is a cutaneous disorder characterized by the presence of several café-au-lait (CAL) macules without any other manifestations of neurofibromatosis or any other systemic disorder.

Epidemiology[edit]

Prevalence is unknown, but the disease appears to be extremely rare.

Cause[edit]

  • The etiology of NF6 remains unknown.
  • Close linkage to the NF1 gene (17q11.2) has been reported in some cases.

Inheritance[edit]

Autosomal dominant pattern, a 50/50 chance.

Transmission is autosomal dominant.

Signs and symptoms[edit]

  • The macules may appear in infancy, but usually they are detected after 2 years of age.
  • CAL lesions are hyperpigmented with smooth or irregular borders.
  • Their size may vary from a few millimeters to more than 10 cm.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

  • Multiple cafe-au-lait spots

5%-29% of people have these symptoms

  • Freckling

Diagnosis[edit]

The diagnosis is based on the presence of six or more CAL macules.

Treatment[edit]

Isolated CAL lesions do not require medical care.

Prognosis[edit]

CAL spots are benign and may resolve with age.


NIH genetic and rare disease info[edit]

Multiple café-au-lait spots is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.